INTRODUCTION
Candida infection, in both the mucocutaneous and systemic forms, has become increasingly prevalent as the number of populations with immunocompromising conditions increases (Miceli et al., 2011; Sardi et al., 2013) . These include patients with human immunodeficiency virus (HIV) infection, cancers and transplantation receiving immunosuppressive therapy. Oropharyngeal candidiasis is one of the most common opportunistic infections associated with HIV disease progression (Patton et al., 2002) . The high incidence of recurrent oropharyngeal candidiasis in HIV-infected and candidaemia in immunocompromised individuals has led to the need for repeated administration and prophylactic use of antifungal agents. Importantly, the emergence of drug resistance has become problematic in several clinical settings (Sardi et al., 2013) .
Whilst Candida albicans remains the predominant species isolated from the oral cavity, a number of studies have shown that non-albicans species have been detected more frequently, especially in immunosuppressed patients (Redding, 2001; Miceli et al., 2011; Sardi et al., 2013) . The non-albicans species most commonly recovered from the oral cavity of HIV-infected and immunocompromised IP: 54.70.40.11
On: Wed, 20 Feb 2019 18:37:53 patients include Candida parapsilosis, Candida glabrata, Candida krusei, Candida tropicalis and Candida dubliniensis (Sardi et al., 2013) . In the majority of cases, non-albicans species are found in mixed infection with C. albicans, although they have occasionally been found as the sole pathogenic species. As several non-albicans species are intrinsically less susceptible to the widely used antifungal agent, fluconazole, accurate species identification is important for treatment choice. Thus, great care is required in the isolation of different Candida species; for instance, the use of a chromogenic differential medium is recommended (Williams & Lewis, 2000) . Furthermore, the identification of C. dubliniensis requires the use of commercial kits or molecular methods, such as PCR, to distinguish it from C. albicans (Loreto et al., 2010) . These techniques had not been employed in previous studies conducted in the Thai population (Itharatana et al., 1997; Teanpaisan & Nittayananta, 1998; Pongsiriwet et al., 2004) , except in a few recent studies (Reichart et al., 2007; Santiwongkarn et al., 2012) . To date, there has not yet been a formal report on the prevalence of C. dubliniensis in the Thai population, particularly in HIV-infected patients. Therefore, currently available data may not fully reflect the prevalence of nonalbicans species, especially in instances of co-colonization. With approximately 500 000 living HIV-infected individuals in Thailand, accurate data on oral Candida colonization in this population are highly relevant (UNAIDS, 2011).
Host immune status of HIV-infected patients is a known risk factor for oral candidiasis; however, various studies have yielded different results with regard to its relationship with oral Candida colonization (Campisi et al., 2002; Vargas & Joly, 2002; Hung et al., 2005; Sánchez-Vargas et al., 2005; Liu et al., 2006; Yang et al., 2006; Erköse & Erturan, 2007; Back-Brito et al., 2009; Delgado et al., 2009; Cerqueira et al., 2010; Domaneschi et al., 2011; Wu et al., 2012) . Moreover, host factors that affect oral colonization of non-albicans and multi-species Candida are not well understood. Therefore, this study was conducted to gain epidemiological data on oral carriage of Candida species in a group of Thai patients with HIV infection in comparison with healthy subjects, and to examine the relationship between host immune status and oral Candida carriage in HIV-infected individuals.
METHODS
Study population. Individuals aged 20-60 years without current oral candidiasis were included in the study. HIV-infected patients (N560) were sampled from participants of the MTCT-Plus initiative at King Chulalongkorn Memorial Hospital of the Thai Red Cross (Abrams et al., 2007) . Control subjects were healthy individuals without any immunocompromising condition (N549) attending the oral diagnostic clinic at the Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
The study protocol was approved by the ethical review boards of the Faculties of Dentistry and Medicine, Chulalongkorn University. All participants were informed of the objectives and study protocol, and gave written consent prior to sample collection.
Data collection. Study subjects were interviewed for data on medical history and routine oral hygiene practice. Current health status of HIVinfected patients was obtained from medical records of the MTCT-Plus initiative program. Oral examination was given to all subjects, and those with oral candidiasis or wearing dentures were excluded from the study.
Oral rinse samples were collected by having each subject hold 10 ml sterile PBS (0.01 M, pH 7.2) in the mouth for 60 s (Samaranayake et al., 1987) . After collection, the samples were placed on ice and transported to the laboratory for microbiological analysis.
Quantification and identification of Candida species. Oral rinse samples were concentrated 10-fold by centrifugation at 3000 r.p.m. for 5 min. Aliquots of 10 and 100 ml were used for inoculation on Sabouraud's dextrose agar (ingredients from Oxoid) and chromogenic Candida agar (Oxoid) media. After 48 h of incubation at 37 uC, yeast colonies grown on each plate were counted and representative colonies of different colours on chromogenic Candida agar were isolated for further analyses. Candida species were identified using chlamydospore formation tests on glutinous rice agar, carbohydrate fermentation tests (substrates from Oxoid) and carbohydrate assimilation tests (API 20C AUX; bioMérieux). Isolates with ambiguous results from biochemical tests were analysed by PCR using species-specific primers as described previously for C. albicans (CAL5-NL4CAL), C. glabrata (CGL1-NL4CGL1), C. parapsilosis (CPA4-NL4LEL1), C. tropicalis (CTR22-NL4CTR1) and C. dubliniensis (CDU2-NL4CAL), and PCR-RFLP using MspI digestion of ITS1-ITS4 PCR products as described (Mannarelli & Kurtzman, 1998; Mirhendi et al., 2006) . All isolates preliminarily identified as C. albicans and C. dubliniensis were distinguished by testing for growth at 45 uC and PCR analysis as described previously (Mannarelli & Kurtzman, 1998; Pinjon et al., 1998) .
Statistical analysis. Characteristics of the two groups were compared using t-tests for continuous data and x 2 or Fisher's exact tests for categorical data. Differences in species distribution were analysed using x 2 and Fisher's exact tests, whilst the quantity of Candida carriage in the two groups was compared using the MannWhitney U test. Multiple logistic regression analyses were used to identify predictors of Candida carriage among HIV-infected patients. Variables with P¡0.25 in bivariate analyses were considered for inclusion in multivariable analyses (Hosmer & Lemeshow, 2000) . Odds ratios (OR) and 95 % confidence intervals (CIs) were calculated for the variables that were statistically significant. All statistical tests were two-sided with a significance level of 5 %.
RESULTS
A total of 60 HIV-infected patients and 49 healthy control subjects were enrolled in this study. Characteristics of the study population are shown in Table 1 . There was no difference between the HIV-positive group and the control group in terms of age, gender, smoking habit, xerostomia, oral hygiene status, hospitalization and pregnancy status. However, the percentages of people using mouthwash and contraceptives were significantly higher in the HIV-positive group than in the control group (P50.007 each).
Prevalence of oral Candida carriage is shown in Table 2 . Overall Candida carriage rates were similar: 56.6 and 55.1 % in the HIV-positive and the control groups, respectively. Moreover, among Candida carriers, there was no difference in the quantity of Candida carriage between HIV-infected (Table 2 ). C. albicans was the most predominant species found in Candida carriers of both groups (94.1 % of HIV, 88.9 % of control), followed by multi-species (41.2 % of HIV, 55.6 % of control) and nonalbicans Candida species (41.2 % of HIV, 44.4 % of control). Amongst non-albicans species, C. dubliniensis and C. parapsilosis were the major species isolated from both groups. Interestingly, C. dubliniensis was quite common, and was isolated from both HIV-infected patients (11.8 %) and the controls (29.6 %, P50.08).
Amongst HIV-infected patients, the prevalence of oral Candida carriage was compared between groups with different medical characteristics ( 
DISCUSSION
This study aims to obtain epidemiological data on oral Candida carriage in Thai HIV-infected individuals compared with healthy controls. The use of chromogenic Candida agar as an isolation medium is significant in facilitating isolation of non-albicans species in samples with more than one species of Candida. Furthermore, to distinguish C. dubliniensis from C. albicans, proper techniques including molecular analysis are critical. Therefore, the dataset could provide a more accurate estimate of the prevalence of non-albicans Candida species in the study population.
When compared with the healthy controls, a higher proportion of subjects in the HIV group used contraceptive drugs (18.3 % in HIV versus 2.0 % in controls, P,0.01) and were pregnant (6.7 % in HIV versus 0 % in controls, P50.13) ( Table 1 ). This is due to the fact that the subjects recruited were participants of the MTCT-Plus initiative, which aims to prevent mother-to-child transmission of HIV infection, and mainly enrols mothers and expecting women along with their families into the program (Abrams et al., 2007) . A higher proportion of HIV-infected patients (18.3 %) compared with controls (2.0 %, P,0.01) regularly used antiseptic mouthwash. This could possibly be explained by the likelihood that the HIV-infected patients were more concerned about their oral infection.
When the prevalence of total Candida carriage was compared, similar rates were observed in the HIV (56.6 %) and control groups (55.1 %; P50.87). This is not surprising considering the well-maintained health status of this group of HIV-infected patients. Ninety-five per cent of the subjects were on highly active antiretroviral therapy or had CD4 counts of .350 cells mm 23 at the time of sample collection.
The prevalence of non-albicans species in healthy controls in this study (24.5 %) is higher than that found in most previous studies in the Thai population (0-19.2 %) (Itharatana et al., 1997; Teanpaisan & Nittayananta, 1998; Pongsiriwet et al., 2004; Santiwongkarn et al., 2012) , although one study had isolated up to 30 % (Itharatana et al., 1997) . In this study, we frequently found that at least one species constituted only a small percentage of the yeast population (0.5-10 %; 68 % of cases with mixed colonization) and cases with one dominant species representing .90 % of total yeast colonies (48 % of cases with mixed colonization, data not shown). These observations emphasize the importance of careful isolation with the use of chromogenic differential medium (Ghelardi et al., 2008) . Of particular interest are the isolation and identification of C. dubliniensis. This is, to our knowledge, the first formal report of the prevalence of C. dubliniensis in the Thai population, especially in HIV-infected individuals. Our results suggested that C. dubliniensis can be found quite frequently even in the healthy population. It is the second most common species isolated in healthy controls and the third in HIV-infected patients in this study. Therefore, our data indicated that C. dubliniensis should not be considered prevalent only in HIV-infected individuals (Loreto et al., 2010; Sardi et al., 2013) .
The prevalence of non-albicans Candida species is of concern as certain Candida species are intrinsically less susceptible to common antifungal agents. For example, C. krusei and C. glabrata (11.5 and 3.3 % of Candida carriers in this study, respectively) are less susceptible to fluconazole and voriconazole, whilst C. parapsilosis and C. tropicalis (21.3 and 4.9 % of Candida carriers, respectively) are as susceptible as C. albicans (Pfaller, 2012) . The identification of causative species is thus important for physicians when choosing appropriate antifungal agents for patients with candidiasis. Nevertheless, the data on the prevalence of Candida species in the oral cavity could be useful for initial treatment choice.
Our findings suggested that CD4 T-lymphocyte count and per cent CD4 are important factors associated with oral Candida carriage even in this group of relatively healthy HIV-infected patients. There was a significant increase in the prevalence of oral Candida, especially of the nonalbicans species, in patients with a lower CD4 count (Table  3) . This is in concordance with earlier studies that observed a higher rate of Candida colonization in patients with low CD4 counts (Vargas & Joly, 2002; Hung et al., 2005; Yang et al., 2006; Wu et al., 2012) ; however, other reports did not find the association (Campisi et al., 2002; Sánchez-Vargas et al., 2005; Liu et al., 2006; Erköse & Erturan, 2007; Back-Brito et al., 2009; Delgado et al., 2009; Cerqueira et al., 2010; Domaneschi et al., 2011) , although none looked specifically at the relationship with nonalbicans species. Interestingly, different populations and geographical locations may affect the outcome, as most studies that observed the association were from Asia, whilst several studies from Europe and South America frequently found otherwise. Another factor that reflects the host immune status of HIV-infected patients is the presence of opportunistic infection. We found a marginally significant association of tuberculosis infection (within 2 years) with Candida colonization (P50.05) and a strong association with the non-albicans species (adjusted OR55.48; ). These findings are consistent with the study of Owotade et al. (2013) who showed a significantly higher rate of tuberculosis infection in the Candida-colonized Oral Candida and immune status in HIV patients group compared with the non-colonized group, although the association with non-albicans species was not investigated. Furthermore, we found a significant association between contraceptive use and oral colonization of nonalbicans Candida species and of multi-species colonization. Interestingly, oral contraceptive use is considered as a predisposing factor for vulvovaginal candidiasis as it could alter hormonal conditions and may promote growth of Candida species (Sobel, 2007) . However, the effect of contraceptive use on colonization of Candida species in the oral cavity has not been well investigated. One study suggested that certain species of Candida were detected more frequently in periodontal pockets of women who used contraceptives (Brusca et al., 2010) . This finding and our results suggest that contraceptive use could also influence oral Candida colonization and should be further investigated.
When compared among HIV-infected patients, the use of antiviral drugs was associated with less Candida, especially of C. albicans, colonization (adjusted P50.03 and 0.02, respectively). This is in agreement with previous reports (Hung et al., 2005; Yang et al., 2006) . However, earlier studies suggested that long-term use of antibiotics for prophylaxis may increase oral Candida carriage, which may in turn increase the risk for future Candida infection (Hung et al., 2005; Wu et al., 2012) . We did not observe a significant association between the use of antibiotics for the prophylaxis of opportunistic infection (mostly trimethoprim/sulfamethoxazole) and oral Candida carriage (P50.09).
History of antifungal drug use for the treatment or prophylaxis of oral candidiasis and other opportunistic fungal infection therapy, especially the use of fluconazole, could lead to a higher prevalence of non-albicans species (Sardi et al., 2013) . Although we did not find a significant difference between the groups of patients with and without a history of antifungal therapy (within 2 years), those with a history showed a higher percentage carrying non-albicans species than those without (37.5 versus 18.2 %, P50.17). As the numbers of patients with a history of antifungal therapy and those with non-albicans species were quite small, the data did not possess sufficient power to detect the difference in this situation. Therefore, a larger number of participants would be required in a future study to address this question.
Furthermore, our findings showed that antiretroviral therapy was associated with a decreased risk of oral Candida carriage. However, we were not able to analyse the effect of different antiretroviral regimens since most of the patients were on similar regimens without the use of protease inhibitors (only one patient received protease inhibitors).
In conclusion, our results suggested that the prevalence of oral Candida carriage was similar between HIV-infected individuals and healthy controls. Host immune status of HIVinfected patients and contraceptive use could influence the colonization of Candida, especially the non-albicans species.
